The European Commission has published a new booklet showing a few examples where EU support for research and innovation is making a real difference in the lives of citizens and society as a whole. It is aimed at all age groups so everyone can understand the good work EU funding can do.
The winning consortia, including also university labs and research centres, should scale up existing research for the benefit of the cybersecurity of the Digital Single Market, with solutions that can be marketable. The experience collected in the selected projects will contribute to the design of the future competence network which will include a European Cybersecurity Research and Competence Centre.
The European Commission is conducting a mapping of the existing centres of expertise in the field of cybersecurity. The results of this mapping will be translated into a "Cybersecurity Atlas" that will be made publicly available. This Atlas aims to become a valuable tool and a reference for the cybersecurity community to look for potential partners and pool resources. Are you a center of excellence in the field of cybersecurity? Then register before 15 February 2018.
The European Commission has launched a new Horizon Prize: "Seamless authentication for all". EUR 4 million is available for inventing secure, privacy-friendly and affordable authentication methods for smart objects available to everyone.
Every cancer follows its own complex path. An EU-funded project is developing experimental tools and a computer model to generate and test ideas on the combined impact of the body's cell and chemical processes on cancer progress. The findings should one day help researchers and SMEs find better-targeted drugs faster.
Technology relies on new ideas. And in recent decades, there has been an explosion of new ideas about materials just a fraction of the size of a human hair. Nanomaterials - materials on the scale of nanometres - promise to improve and even revolutionise products from electricity cables to personal electronics to solar panels.
PANA has set out to develop an innovative method to diagnose Alzheimer's in its early stages, up to five years before the occurrence of clinical symptoms. This could increase the duration and quality of patients' lives considerably.